Incyte (INCY) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 5.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.16% |
| Dec 31, 2025 | -13.33% |
| Sep 30, 2025 | -20.95% |
| Jun 30, 2025 | 14.07% |
| Mar 31, 2025 | 2.01% |
| Dec 31, 2024 | 19.55% |
| Sep 30, 2024 | 62.34% |
| Jun 30, 2024 | 3.89% |
| Mar 31, 2024 | 11.99% |
| Dec 31, 2023 | 13.88% |
| Sep 30, 2023 | 5.72% |
| Jun 30, 2023 | 17.25% |
| Mar 31, 2023 | 21.76% |
| Dec 31, 2022 | 9.24% |
| Sep 30, 2022 | 6.33% |
| Jun 30, 2022 | 3.79% |
| Mar 31, 2022 | -7.43% |
| Dec 31, 2021 | 6.54% |
| Sep 30, 2021 | -2.51% |
| Jun 30, 2021 | -3.24% |
| Mar 31, 2021 | 11.40% |
| Dec 31, 2020 | 7.71% |
| Sep 30, 2020 | 0.92% |
| Jun 30, 2020 | 14.04% |
| Mar 31, 2020 | 4.71% |
| Dec 31, 2019 | 12.36% |
| Sep 30, 2019 | 14.21% |
| Jun 30, 2019 | 10.93% |
| Mar 31, 2019 | 12.08% |
| Dec 31, 2018 | 10.80% |
| Sep 30, 2018 | 8.88% |
| Jun 30, 2018 | 8.28% |
| Mar 31, 2018 | 18.38% |
| Dec 31, 2017 | 22.30% |
| Sep 30, 2017 | 31.70% |
| Jun 30, 2017 | 58.69% |
| Mar 31, 2017 | 47.12% |
| Dec 31, 2016 | 61.40% |
| Sep 30, 2016 | 50.57% |
| Jun 30, 2016 | 21.02% |
| Mar 31, 2016 | 18.46% |
| Dec 31, 2015 | 7.53% |
| Sep 30, 2015 | 13.55% |
| Jun 30, 2015 | 13.55% |
| Mar 31, 2015 | 14.41% |
| Dec 31, 2014 | 62.28% |
| Sep 30, 2014 | 63.16% |
| Jun 30, 2014 | 56.57% |
| Mar 31, 2014 | 66.87% |
| Dec 31, 2013 | 8.08% |
| Sep 30, 2013 | 0.00% |
| Jun 30, 2013 | 0.00% |
| Mar 31, 2013 | -7.40% |
| Dec 31, 2012 | 21.17% |
| Sep 30, 2012 | 28.38% |
| Jun 30, 2012 | 37.50% |
| Mar 31, 2012 | 43.94% |
| Dec 31, 2011 | 79.66% |
| Sep 30, 2011 | 80.49% |
| Jun 30, 2011 | 100.00% |
| Mar 31, 2011 | 121.08% |